17.09.2015 Views

ST SEBASTIAN’S

Issue I - St. Sebastian's School

Issue I - St. Sebastian's School

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SCIENCE<br />

The Road to Novartis<br />

Matt LaMarche '93 describes the journey from the classrooms at St. Sebastian's to the<br />

laboratory of Novartis.<br />

By Dan Tobin<br />

Germs… they’re everywhere. They wait to attack us when<br />

we least expect it. They cause us to cough, to sneeze, and<br />

to run a fever. They sap us of our energy and our appetite.<br />

If we’re lucky, our immune system kicks into high gear and, in a<br />

day or two, beats back the viruses and bacteria that have set up<br />

shop in our bodies.<br />

Sometimes, however, the grasp on our system is too much for<br />

our bodies to handle and we need to call in reinforcements to help in<br />

our fight against the invaders. In these cases, we rely on the<br />

experience of our doctors, the men and women who have a treasure<br />

chest of pills and potions at their disposal.<br />

But, from where do those pills and potions come?<br />

Matt LaMarche ’93 can answer that one.<br />

What He Does<br />

Matt LaMarche is a Medicinal Chemist and Project Team Leader<br />

for Novartis Institutes for Biomedical Research in Cambridge.<br />

“I’m in drug discovery research,” stated LaMarche. “I’m a<br />

research chemist who identifies compounds that are drug<br />

candidates. Right now I am working in infectious disease, medicinal<br />

chemistry.”<br />

More specifically, LaMarche’s team is currently working on an<br />

anti-viral project for Hepatitis C. As Team Leader for the project, he<br />

has to identify the strategy and how the team is going to attack the<br />

disease. Basically, there is a protein target they are trying to<br />

modulate with small molecules. LaMarche is responsible for the<br />

chemistry strategy and the overall project strategy for how the team<br />

will modulate the target to affect the disease.<br />

“Part of my job is to run the lab,” LaMarche commented. “I<br />

oversee two medicinal chemists who execute reactions and<br />

purifications in the lab. They combine chemicals in organic<br />

synthesis reactions to make more complex molecules, then purify<br />

those materials and submit them to our biologists, who measure<br />

whether or not the compounds have the desired biological activity or<br />

not.”<br />

As the Team Leader, LaMarche is there to help with the<br />

optimization of those reactions and purifications. He is also<br />

Matt LaMarche with his wife, Ellen, and their children, Julia and<br />

Madeline.<br />

38 | <strong>ST</strong>. SEBA<strong>ST</strong>IAN’S MAGAZINE Volume V, Issue I

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!